Evidence map›Paper›PMID 30431339›Full record

ReviewAnnals of the American Thoracic Society2018

Airway Mucin Secretion.

Ana M Jaramillo, Zoulikha Azzegagh, Michael J Tuvim, Burton F Dickey

Open access · greenAbstract readReview
In one paragraph

Review in Annals of the American Thoracic Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 61 citations in OpenAlex.

  1. Airway secretory cells contain both a perinuclear Golgi ribbon and dispersed Golgi satellites.American journal of respiratory cell and molecular biology · 2026
    Article
  2. Structural and cellular mechanisms of mucus plugging in the larger airways.Chinese medical journal pulmonary and critical care medicine · 2026
    Review
  3. Airway mucus in infection.Frontiers in physiology · 2026
    Review
  4. Mucins and Their Roles in Asthma.Immunological reviews · 2025
    Review
  5. Article
  6. Pulmonary-delivered Anticalin Jagged-1 antagonists reduce experimental airway mucus hyperproduction and obstruction.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  7. Article
  8. Mucociliary clearance is impaired in small airways of cystic fibrosis pigs.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  9. Article
  10. Emerging cell and molecular targets for treating mucus hypersecretion in asthma.Allergology international : official journal of the Japanese Society of Allergology · 2024
    Review
  11. Article
  12. Review
  13. Review
  14. [Clinical characteristics of plastic bronchitis and risk factors for recurrence in children].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ana M JaramilloDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0001-8089-4275
Zoulikha AzzegaghDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0001-7375-8785
Michael J TuvimDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0001-8126-7716
Burton F DickeyDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0002-4780-1847
The University of Texas MD Anderson Cancer Center · US

Funding

Controlling the core airway mucin secretion machinery to prevent pathophysiologyR01HL129795 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DICKEY, BURTON F · 2015 to 2023
$3.8M
Roles of Synaptotagmin-2 in Airway ObstructionR21AI137319 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ADACHI, ROBERTO · 2018 to 2019
$440k
Targeting Synaptotagmin-2 to Prevent Airway Mucus ObstructionR41HL136057 · NHLBI · EXOTECT, LLC · PI DICKEY, BURTON F, VARADHACHARY, ATUL · 2017 to 2017
$225k
NHLBI NIH HHS R01 HL129795NHLBI NIH HHS R41 HL136057NIAID NIH HHS R21 AI137319
6 · The paper itself

Abstract

Exocytosis of secreted mucins is the final step in their intracellular processing, resulting in their release into the airway lumen to interact with water and ions to form mucus. Mucins are secreted at a low baseline rate and a high stimulated rate, and both rates are regulated by second messengers acting on components of the exocytic machinery. The principal physiologic function of the low baseline rate is to support steady-state mucociliary clearance of inhaled particles and pathogens that enter the airways during normal breathing. Even in the setting of mucin hyperproduction, baseline secretion generally does not induce mucus occlusion. The principal physiologic function of the high stimulated rate of secretion from both submucosal glands and surface goblet cells in proximal airways appears to be to sweep away larger particles, whereas in distal airways it appears to act in concert with mucin hyperproduction to induce mucus occlusion to trap migrating helminths. Pathophysiologically, stimulated mucin secretion in the setting of mucin hyperproduction from allergic or other types of airway inflammation in the absence of helminth infection causes airflow obstruction and infection. Molecular components of the mucin exocytic machinery are increasingly being identified, and surprisingly, many components are not shared between baseline and stimulated machines. The physiologic significance of the presence of two distinct molecular machines is not yet known, such as whether these interact selectively with secretory granules of different sizes or contents. A full understanding of the mechanism and regulation of airway mucin secretion will provide further insight into pathophysiologic processes and may identify therapeutic strategies to alleviate obstructive airway diseases.

Indexed as

ExocytosisHumansLung DiseasesMucinsMucociliary ClearanceMucusRespiratory MucosaSecretory VesiclesMucinsexocytosismucinmucussecretion

Identifiers

PMID30431339
PMCPMC6322024
OpenAlexW2901953504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.